Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Nov 23 2021

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-23-2021-9

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 23, 2021, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Dabigatran Etexilate Capsules, 150 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases